Literature DB >> 28160005

The funding lottery for potentially life-threatening rare diseases.

Joseph A Roscamp1, David P D'Cruz1.   

Abstract

Mesh：

Year:  2018        PMID： 28160005     DOI： 10.1093/rheumatology/kex004

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  2 in total

Review 1.  A systematic review of moral reasons on orphan drug reimbursement.

Authors:  Bettina M Zimmermann; Johanna Eichinger; Matthias R Baumgartner
Journal:  Orphanet J Rare Dis       Date:  2021-06-30       Impact factor: 4.123

2.  Moving somatic gene editing to the clinic: routes to market access and reimbursement in Europe.

Authors:  Tessel Rigter; David Klein; Stephanie S Weinreich; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2021-04-14       Impact factor: 4.246
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.